 Home > Medical News > Latest Medical News > Controversy between Me-too and FIC routes

Controversy between Me-too and FIC routes

 Last Update: 2021-08-06
 Source: Internet
 Author: User

Tags

sugar bad cancer

new society publishers

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

The recent value-oriented document issued by CDE has caused the industry to debate which of the two routes, me-too and FIC, is better

Drug source analysis

The dispute between these two lines has been around for a long time, and no one has been able to convince each other

First, the basic concepts

Merck is the most successful pharmaceutical company in history.

Although me-too also has blockbuster drugs, neither the drug king Lipitor nor Xiu Mei Le is the first

Technically speaking, me-too is less risky, but market risk is greater.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.